GlassScriptPhysician profile
Clara L Herrin
NPI 1346428356
$916.85
in general payments reported to CMS, 2019-2025
18 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.47 · 2023: $77.40 · 2024: $418 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $121.60 | 2024 | Veozah |
| Novo Nordisk INC | $105.13 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $85.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $83.33 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $73.18 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $59.10 | 2024-2025 | |
| Glaxosmithkline, LLC. | $57.94 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $56.97 | 2024-2025 | Zepbound, Kisunla, Mounjaro |
| Merck Sharp & Dohme LLC | $50.04 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Baxter Healthcare | $46.32 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $36.71 | 2024-2025 | Evenity, Prolia, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $35.38 | 2019-2024 | |
| Sanofi Pasteur INC. | $21.31 | 2025 | |
| Abbott Laboratories | $20.20 | 2025 | Freestyle Libre 3 |
| Dexcom, INC. | $18.16 | 2023 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.80 | 2023 | Tirosint, Licart |
| Sanofi-Aventis U.S. LLC | $14.62 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.46 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Herrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.